The BTA is delighted to announce that Cerus Corporation has joined the association’s membership.
Cerus is a company with a three-decade history in the field of transfusion medicine, with a consistent and unwavering focus on securing blood safety and availability around the globe.
Cerus is dedicated solely to safeguarding the world’s blood supply. The company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The company’s technology is a system for pathogen inactivation of platelets and plasma that is available globally.
Visit Cerus.com to learn more.